Kursprognose für Pacific Biosciences of California Inc (PACB)PACBPacific Biosciences of California Inc

Alphio's PACB stock price prediction model matches the current Pacific Biosciences of California Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.72 (-0.57%). The 1-week path is $1.85 (+6.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Given the current price of $2.33, the stock is not a strong buy at this moment. The RSI is at 52.275, indicating a neutral momentum, and the forward P/E is at 0, suggesting uncertainty in future earnings. The recent revenue guidance cut to $155 million to $165 million raises concerns about financial stability. However, the stock has shown a significant 79.23% increase over the last 20 days, indicating potential for recovery. The main risk is the net income loss of $44.7 million reported in Q2 2026, which could impact investor confidence.

Pacific Biosciences of California Inc (PACB) last closed at $1.73, losing -11.73%. These facts feed the 1-day and 1-week PACB price prediction above.